InnerOptic Technology (Hillsborough, NC) received FDA 510(k) clearance to bring to market its AIM software for ultrasound guided needle placement. AIM takes advantage of electromagnetic tracking to display the locations of the needle and ultrasound transducer on a 3D monitor. 
The technology can help physicians perform all sorts of image guided procedures including catheterizations, nerve blocks, in vitro fertilizations, tumor ablations and biopsies. The system is also compatible with laparoscopic interventions.
The software is currently compatible with ultrasounds from BK Medical and Aloka, as well as interventional devices from Halt Medical and Microsulis.
From the product page:
The AIM software displays an ablation volume guide. The ablation volume guide shows the physician which tissue area may be ablated, before the ablation takes place. This provides the physician with the confidence that the ablation needle/antenna is properly positioned, maximizing the destruction to the tumor while minimizing the damage to healthy tissue. As shown below, The ablation field is identified by AIM as the tumor is visualized with the use of color flow Doppler imaging.
Product page: InnerOptic AIM…
Press release: INNEROPTIC’S AIM™ SYSTEM RECEIVES FDA 510(K) CLEARANCE
